Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-21, Stock:LLY, The news for the past five days is as follows:
2019-06-14: NEWS1: U.S. drugmakers file lawsuit against rule requiring drug prices in TV ads.NEWS2: Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod.NEWS3: Lilly Presents Positive Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress of Rheumatology.NEWS4: Drugmakers sue to stop rule requiring prices in TV ads.
2019-06-17: NEWS1: Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon.NEWS2: Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon.NEWS3: Pfizer Expands in Cancer With $10.6 Billion Deal for Array.NEWS4: Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth.NEWS5: Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice.
2019-06-18: NEWS1: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS2: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS3: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS4: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS5: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS6: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS7: Shares of cancer-therapy companies skyrocket after Pfizer acquisition news.
2019-06-19: NEWS1: Daily Dividend Report: FITB, HBNC, LLY, EQR, CUZ.NEWS2: Daily Dividend Report: FITB, HBNC, LLY, EQR, CUZ.NEWS3: Lilly Declares Third-Quarter 2019 Dividend.
2019-06-20: NEWS1: 3 Drugs Under FDA Review With Blockbuster Potential.NEWS2: 3 Drugs Under FDA Review With Blockbuster Potential.NEWS3: Allergan Up As Analyst Statement Sparks Business Split Rumors.NEWS4: Allergan Up As Analyst Statement Sparks Business Split Rumors.NEWS5: Opinion: Medical Marijuana Is a Terrible Investment.NEWS6: Opinion: Medical Marijuana Is a Terrible Investment.NEWS7: Implied EPS Analyst Target Price: $36.NEWS8: Implied EPS Analyst Target Price: $36.

Answer: Decrease